If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHNT.L Share News (HNT)

  • There is currently no data for HNT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Huntsworth Agrees GBP400 Million Cash Offer From US Private Equity

Tue, 03rd Mar 2020 10:46

(Alliance News) - Huntsworth PLC on Tuesday posted a rise in 2019 profit and said that it has agreed to a cash takeover offer valuing the company's share capital at GBP400 million.

CD&R Artemis UK Bidco Ltd, an entity formed by US private equity Clayton Dubilier & Rice LLP, will pay 108 pence per share in cash for healthcare and communications firm Huntsworth. This represents around a 50% premium to the company's 72.0p per share Monday closing price.

On Tuesday morning, shares in Huntsworth were up 51% at 109.00p in London.

The implied enterprise value of the acquisition, intended to be implemented through a court-sanctioned scheme of arrangement, is GBP524 million.

The deal has been unanimously recommended by Huntsworth's directors. Clayton Dubilier has received irrevocable undertakings from Merian Global Investors (UK) Ltd and Hargreave Hale Ltd- holding a combined 14% take in Huntsworth.

Letters of intent to vote in favour have also been received from Aberforth Partners LLP, Kabouter Management LLC and Kames Capital, holding a combined 22% stake. With these and director acceptances, Clayton Dubilier has acceptances representing 37% of Huntsworth's share capital.

Huntsworth's 2019 pretax profit totaled GBP29.8 million, up 4.2% from GBP28.6 million. This resulted from an 18% revenue rise to GBP264.9 million from GBP225.0 million, including a 32% rise in Marketing revenue to GBP108.3 million from GBP82.0 million and 32% Medical revenue rise to GBP45.1 million from GBP34.2 million, thanks to acquisitions.

The company has proposed a final 1.85p per share dividend, taking the total for 2019 up 13% to 2.6p per share from 2.3p per share.

Huntsworth Chief Executive Paul Taaffe said: "Huntsworth had yet another record year led by growth in our Medical and Immersive divisions and a return to growth in Communications. Organic revenue growth accelerated over the course of the year and the acquisitions of Kyne in Marketing and Creativ-Ceutical in Medical both contributed to 2019 performance and further enhanced our capability to attract larger and higher-margin client engagements.

"We have entered 2020 well positioned for another year of growth with strong momentum at the start of the financial year and an increased new business pipeline."

On the takeover offer, Taaffe said: "Whilst we believe that Huntsworth is strongly positioned as an independent listed company, the all-cash offer from CD&R represents a compelling opportunity for shareholders to realise an attractive cash value in respect of their shares."

By Anna Farley; annafarley@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
27 Nov 2018 12:26

Tuesday broker round-up

(Sharecast News) - Pets At Home Group: Liberum downgrades to hold with a target price of 120p.

Read more
28 Sep 2018 11:28

Friday broker round-up

(Sharecast News) - Huntsworth: Berenberg reiterates buy with a target price of 150p.

Read more
16 Aug 2018 13:09

Thursday broker round-up

(Sharecast News) - Esure Group: UBS upgrades to neutral with a target price of 280p.

Read more
16 Aug 2018 12:04

Berenberg ups target price on Huntsworth after 'better than expected' first half

(Sharecast News) - Analysts at Berenberg updated their forecasts on Huntsworth following the healthcare and communications group's "better than expected" first half.

Read more
24 Jul 2018 10:39

Huntsworth Interim Profit And Revenue Up Despite Tough Conditions

LONDON (Alliance News) - Huntsworth PLC said on Tuesday that seasonal timings and client mix change caused a net cash outflow in the first half of 2018, despite rise in profit and in the group at

Read more
24 May 2018 14:56

Huntsworth Reports Strong Trading In First Four Months Of 2018

LONDON (Alliance News) - Healthcare and communications group Huntsworth PLC said on Thursday it traded well in the first four months of 2018.The Medical and Immersive divisions saw strong a

Read more
17 May 2018 16:01

UK Shareholder Meetings Calendar - Next 7 Days

Friday 18 MayPaddy Power BetfairIndependent News & (T)PetrofacJohn Group (re by

Read more
17 May 2018 16:00

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 18 May AstraZenecaQ1 ResultsHikma PharmaceuticalsTrading ClarkeTrading 21

Read more
16 Feb 2017 10:09

Huntsworth improves investor relations with profit upgrade

(ShareCast News) - Public relation group Huntsworth has revealed 2016 trading was ahead of consensus forecasts thanks to strong growth at its health communications arm. Analysts at house broker Numis raised their PBT and EPS forecast by 3% to £15.5m and 3.4p, with the consensus range for headline PB

Read more
16 Dec 2016 17:07

DIRECTOR DEALINGS: Huntsworth Executive Buys 15,000 Shares

Read more
10 Nov 2016 16:23

DIRECTOR DEALINGS: Huntsworth Chief Executive Buys 100,000 Shares

Read more
9 Nov 2016 16:17

DIRECTOR DEALINGS: Chief Financial Officer Neil Jones Buys Shares

Read more
28 Oct 2016 15:04

UK Dividends Calendar - Next 7 Days

Read more
27 Jul 2016 09:52

Director dealings: Huntsworth trio load up on shares

(ShareCast News) - A trio of Huntsworth directors bought shares in the marketing and communications group the evening after its interim results. Chairman Derek spent £66,500 at 40.1p, chief executive Paul Taaffe £39,650 at 39.65p and finance director Neil Jones just over £35,800 at 39.82p, the compa

Read more
26 Jul 2016 17:03

DIRECTOR DEALINGS: Huntsworth Chairman Mapp Buys Shares

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.